María Gaibar

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 29, 2026
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.

|Feb 26, 2022
FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.

María Gaibar, Apolonia Novillo, Alicia Romero-Lorca

|Oct 07, 2021
miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer.

Alicia Romero-Lorca, Apolonia Novillo, María Gaibar

|Apr 08, 2020
Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.

Maria Gaibar, Laura Beltrán, Alicia Romero-Lorca

Pageof 1

Frequent Collaborators

4 joint publications

Ana Fernández-Santander

3 joint publications

Apolonia Novillo

2 joint publications

Alicia Romero-Lorca

1 joint publications

J M Rodríguez-Piñas